which he was successfully surgically treated at the age of 16 months. Early developmental milestones were delayed. The patient presented with febrile seizures at the age of 12 months. From 3 years of age, afebrile epileptic seizures in terms of generalised atonic, myoclonic, and tonic-clonic seizures were observed. Despite treatment, the epilepsy was intractable. Clinical examination at 32 years of age revealed moderate-to-severe mental retardation, normal stature (185 cm, 87 kg), osteoporosis, slight scoliosis, friendly mood, and a high-pitched voice. The patient had normal vision, normal hearing, and normal sexual maturation.
Genome-Wide Human SNP Array 6.0 (Affymetrix) performed on DNA from peripheral blood lymphocytes revealed a 0.5-Mb duplication at chromosome Xp11.3 (chrX: 43290667-43794205, Hg18) (Figure 1 ). The duplication included the MAOA, MAOB, and NDP genes, and was validated using real-time quantitative PCR (qPCR) and the 2(ÀDelta Delta C(T)) method. One control region outside and four exonic regions inside the duplicated region were amplified using GAPDH as an internal standard (Supplementary Figure 1) .
In this patient, a total of 16 copy number variants (CNVs) of minimum 100 kb were detected (Table 1) . Only four of these did not overlap completely with known CNVs reported in the Database of Genomic Variants, and of these only the Xp11.3 duplication contained RefSeq genes. The three other unknown CNVs did not overlap with reported non-genic regulatory landscapes 2-4 around key developmental genes, making it less likely that they could be pathogenic, for example, involved in long-range position effects.
Reciprocal deletions and duplications of several genes/loci may result in either different or similar clinical features depending on the Only one of the two previously reported duplications of Xp11.3 6,7 has been molecularly characterised -Tzschach et al 7 described a male patient with mental retardation and epilepsy carrying an inherited 9.3-Mb duplication including MAOA, MAOB, and NDP. Our patient with a much smaller duplication involving only NDP, MAOA, and MAOB also presented with mental retardation and epilepsy. Combined, these findings support that tight dosage regulation of one or more of the three genes is important for normal cognitive function and development of the central nervous system. In contrast to the two patients with Xp11.3 duplication described in the literature, our patient was not obese but only slightly overweight (BMI¼25.4). Thus, MAOA is not the only gene determining obesity, consistent with a multifactorial aetiology of obesity. 8 The identification of additional cases with Xp11.3 duplications should further contribute to delineation of the associated clinical spectrum and elucidate the specific candidate gene(s) for mental retardation and epilepsy. In total, this patient had 16 CNVs, whereof one partially overlaps with a known CNV and three did not overlap any known CNV region. The 0.5-Mb duplication of Xp11.3 is shown in bold.
